Cargando…

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis

Nonsevere Clostridium difficile infection (CDI) and severe CDI, which carries a higher risk than nonsevere CDI for treatment failure and CDI recurrence, are difficult to distinguish at the time of diagnosis. To investigate the prognostic value of 3 markers of severe CDI suggested by recent guideline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Martijn P., Hensgens, Marjolein P. M., Miller, Mark A., Gerding, Dale N., Wilcox, Mark H., Dale, Adam P., Fawley, Warren N., Kuijper, Ed J., Gorbach, Sherwood L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388022/ https://www.ncbi.nlm.nih.gov/pubmed/22752864 http://dx.doi.org/10.1093/cid/cis340

Ejemplares similares

Clostridium difficile Infection Caused by Binary Toxin–Positive Strains
por: Hensgens, Marjolein P.M., et al.
Publicado: (2013)

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
por: Figueroa, Iris, et al.
Publicado: (2012)

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
por: Cornely, Oliver A., et al.
Publicado: (2012)

High Prevalence of Clostridium difficile Colonization among Nursing Home Residents in Hesse, Germany
por: Arvand, Mardjan, et al.
Publicado: (2012)

Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078
por: Keessen, Elisabeth C, et al.
Publicado: (2013)

The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection
por: Gerding, Dale N., et al.
Publicado: (2017)

Seasonality of Clostridium difficile infections in Southern Germany
por: REIL, M., et al.
Publicado: (2012)

Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains
por: Nale, Janet Y., et al.
Publicado: (2012)

Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
por: Gerding, Dale N., et al.
Publicado: (2018)

Clostridium difficile infection in an endemic setting in the Netherlands
por: Hensgens, M. P. M., et al.
Publicado: (2010)

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
por: Crook, Derrick W., et al.
Publicado: (2012)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164
por: Corver, Jeroen, et al.
Publicado: (2012)

Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
por: Gerding, Dale N, et al.
Publicado: (2014)

Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile
por: Fawley, Warren N., et al.
Publicado: (2015)

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
por: Eyre, David W., et al.
Publicado: (2012)

Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
por: Martin, Jessica S H, et al.
Publicado: (2018)

Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

Evolutionary History of the Clostridium difficile Pathogenicity Locus
por: Dingle, Kate E., et al.
Publicado: (2013)

Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012)

Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia
por: Salazar, Clara Lina, et al.
Publicado: (2017)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
por: Soriano, Melinda M., et al.
Publicado: (2014)

Current Status of Clostridium difficile Infection Epidemiology
por: Lessa, Fernanda C., et al.
Publicado: (2012)

Current State of Clostridium difficile Treatment Options
por: Venugopal, Anilrudh A., et al.
Publicado: (2012)

Fidaxomicin Inhibits Spore Production in Clostridium difficile
por: Babakhani, Farah, et al.
Publicado: (2012)

Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA
por: Jump, Robin L.P., et al.
Publicado: (2010)

Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains
por: Stoesser, Nicole, et al.
Publicado: (2017)

Effects of control interventions on Clostridium difficile infection in England: an observational study
por: Dingle, Kate E, et al.
Publicado: (2017)

The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016
por: Novakova, Elena, et al.
Publicado: (2020)

Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
por: Dingle, Kate E., et al.
Publicado: (2011)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

Clostridium difficile infection: review
por: Czepiel, Jacek, et al.
Publicado: (2019)

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis
por: Dubberke, Erik R., et al.
Publicado: (2016)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Toxinotype V Clostridium difficile in Humans and Food Animals
por: Jhung, Michael A., et al.
Publicado: (2008)

Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing
por: Eyre, David W., et al.
Publicado: (2017)

Emergence and global spread of epidemic healthcare-associated Clostridium difficile
por: He, Miao, et al.
Publicado: (2012)

Typing Clostridium difficile strains based on tandem repeat sequences
por: Zaiß, N Henning, et al.
Publicado: (2009)

Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia
por: Salazar, Clara Lina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oe41a2ao6l66cs62dgtbh3olor